Your search returned the following 7 documents:

7. Peptidomimetic Escape Mechanisms Arise via Genetic Diversity in the Ligand-Binding Site of the Hepatitis C Virus NS3/4A Serine Protease
   Christoph Welsch, Tetsuro Shimakami, Christoph Hartmann, Yan Yang, Francisco S. Domingues, Thomas Lengauer, Stefan Zeuzem, and Stanley M. Lemon
   Gastroenterology 142 (3): 654-663, 2012
   
6. Comparison of Envelope 2 CD81 binding regions in PBMC-derived versus serum-derived hepatitis C virus isolates: higher conservation of CD81 region 2 in PBMC isolates
   M.-W. Welker, Christoph Welsch, D. Ochs, W. P. Hofmann, E. Herrmann, A. Piiper, R. W. Hartmann, S. Zeuzem, C. Sarrazin, and Bernd Kronenberger
   Journal of Viral Hepatitis 18 (3): 181-192, 2011
   
5. Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients.
   Simone Susser, Christoph Welsch, Yalan Wang, Markus Zettler, Francisco S. Domingues, Ursula Karey, Eric Hughes, Robert Ralston, Xiao Tong, Eva Herrmann, Stefan Zeuzem, and Christoph Sarrazin
   Hepatology 50 (6): 1709-1718, 2009
   
4. Molecular basis of telaprevir resistance due to V36 and T54 mutations in the NS3-4A protease of HCV
   Christoph Welsch, Francisco S. Domingues, Simone Susser, Iris Antes, Christoph Hartmann, Gabriele Mayr, Andreas Schlicker, Christoph Sarrazin, Mario Albrecht, Stefan Zeuzem, and Thomas Lengauer
   Genome Biology 9 (1): R16 p., 2008
   [PDF: Download: Welsch2008.pdf]
   
3. Structural and functional comparison of the non-structural protein 4B of flaviviridae
   Christoph Welsch, Mario Albrecht, Jochen Maydt, E. Herrmann, M.W. Welker, C. Sarrazin, A. Scheidig, Thomas Lengauer, and S. Zeuzem
   Journal of Molecular Graphics and Modeling 26 (2): 546-557, 2007
   
2. Association of HCV-related mixed cryoglobulinemia with specific mutational patterns of the HCV E2 protein and CD81 expression on peripheral B lymphocytes
   W.P. Hofmann, E. Herrmann, B. Kronenberger, Christian Merkwirth, Christoph Welsch, Thomas Lengauer, S. Zeuzem, and C. Sarrazin
   Blood 104 (4): 1228-1229, 2004
   
1. Clinical significance of in vitro replication-enhancing mutations of the hepatitis C virus (HCV) replicon in patients with chronic HCV infection.
   Thomas Lengauer, Mario Albrecht, C. Sarrazin, U. Mihm, E. Herrmann, Christoph Welsch, U. Sarrazin, S. Traver, and S. Zeuzem
   Journal of Infectious Diseases 192 (10): 1710-1719, 2005